NCT05912413 Predicton of Sepsis Recovery Performance Subtypes Pilot Study
| NCT ID | NCT05912413 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-07-11 |
| Primary Completion | 2027-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2023-07-11 with a primary completion date of 2027-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study addresses critically ill sepsis patients' current literature reports of ongoing post-hospital discharge weakness and hospital readmissions. This study is aimed at capture and interpretation of a complex set of tests, administered during a subject's sepsis functional recovery trajectory, particularly capturing hospital readmission's effects on survivors' physical function recovery.
Eligibility Criteria
Inclusion Criteria: * Sepsis requiring organ support in an ICU setting Exclusion Criteria: 1. inability to obtain informed consent 2. the attending physician reports that the patient's goals of care are transitioning to palliation/withdrawal of life-sustaining therapy 3. recent cancer therapy in the last 12 months 4. age \>80 5. plans to be discharged on mechanical ventilation to a Long Term Acute Care Hospital 6. planned discharge to rehabilitation facility, long-term hospital or nursing home. 7. Pregnancy
Contact & Investigator
peter morris, md
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham
Frequently Asked Questions
Who can join the NCT05912413 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05912413 currently recruiting?
Yes, NCT05912413 is actively recruiting participants. Contact the research team at pmorris@uabmc.edu for enrollment information.
Where is the NCT05912413 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT05912413 clinical trial?
NCT05912413 is sponsored by University of Alabama at Birmingham. The principal investigator is peter morris, md at University of Alabama at Birmingham. The trial plans to enroll 40 participants.